Characteristics and outcomes of patients with pregnancy-associated colorectal cancer
The Oncologist · 2025
DOI: 10.1093/oncolo/oyaf377 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2025. Verfasst von Guihui Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Pregnancy Complications, Neoplastic. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Shenzhen San-Ming Project of Medicine.
Abstract (Originalsprache)
Introduction
Pregnancy-associated colorectal cancer (PACRC) is a rare condition with limited existing research. Its occurrence during pregnancy introduces unique physiological complexities, making diagnosis and treatment particularly challenging for clinicians. This study aimed to characterize PACRC by examining its clinical features, obstetric management approaches, therapeutic strategies, and maternal-fetal survival outcomes.
Methods
A comprehensive literature review was conducted using studies published from January 2016 to March 2024. Cox proportional hazards regression was used to identify prognostic factors affecting overall survival (OS). Chi-square tests were used to assess differences in fetal mortality and preterm birth rates across exposure groups.
Results
A total of 121 PACRC patients were included, and most were diagnosed in late pregnancy or postpartum. PACRC was more frequently located in the left colon and rectum, typically diagnosed at advanced stages. Most tumors were moderately or poorly differentiated adenocarcinomas. The 1-year and 2-year maternal survival rates were 69.90% and 58.60%, respectively. Prognosis was more favorable when the tumor is in the rectum rather than the colon. Surgical intervention and chemotherapy, particularly when initiated during pregnancy, were associated with significantly improved outcomes compared to postpartum therapy (HR = 0.36; 95% CI: 0.16-0.84; P = .02). Fetal mortality was not directly associated with prenatal diagnostic or therapeutic procedures, although iatrogenic pregnancy termination may contribute to fetal risk.
Conclusions
PACRC, characterized by its subtle presentation, requires vigilant clinical monitoring and prompt intervention, with consideration of gestational age, histological type, and tumor stage. Our findings suggest that early surgical intervention and chemotherapy during pregnancy may offer greater survival benefits than treatment initiated only after pregnancy termination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
- Medical College, Shantou University, Shantou, Guangdong 515041, P.R. China.
- Department of Oncology, Shenzhen Xinhua Hospital, Shenzhen, Guangdong 518055, P.R. China.
- Peking University Health Science Center, Beijing 100191, P.R. China.
- Clinical Research Academy, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China.
ORCID-Profile: Guihui Wang, Jing Gao
Förderung
- Shenzhen San-Ming Project of Medicine
Zitieren
APA
Wang, G., Zhang, Z., Liao, H., Zhu, Y., Hu, Z., Wang, S., & Gao, J. (2025). Characteristics and outcomes of patients with pregnancy-associated colorectal cancer. The Oncologist. https://doi.org/10.1093/oncolo/oyaf377
Vancouver
Wang G, Zhang Z, Liao H, Zhu Y, Hu Z, Wang S, et al. Characteristics and outcomes of patients with pregnancy-associated colorectal cancer. The Oncologist. 2025. doi:10.1093/oncolo/oyaf377
BibTeX
@article{Wang2025,
author = {Wang, Guihui and Zhang, Zhixun and Liao, Haiyan and Zhu, Yiming and Hu, Ziyu and Wang, Shubin and Gao, Jing},
title = {Characteristics and outcomes of patients with pregnancy-associated colorectal cancer},
journal = {The Oncologist},
year = {2025},
doi = {10.1093/oncolo/oyaf377}
}
EUVIMED